add share buttonsSoftshare button powered by web designing, website development company in India

FDA Warnings Regarding Statins and Type II Diabetes

Monday , 19, April 2021 Comments Off on FDA Warnings Regarding Statins and Type II Diabetes

Odds are you have seen the advertisements on TV and in magazines such as cholesterol-lowering drugs, called statins, with new names like Lipitor, Zocor, and Crestor. Statins block an essential step in the creation of LDL cholesterol from the liver. Countless people choose them in a bid to reduce and protect against cardiovascular disease, the main cause of death for both women and men in the world.

Like most such advertisements, they comprise lengthy health warnings and disclaimers. Odds are, through time, you have grown somewhat numb to these warnings, but here is something you need to pay attention to that the FDA has just enlarged warnings based on many studies which suggest women taking statins are greatly increasing their risk of developing Type II diabetes. You can check out the services of Wizmed as it provides you an adequate database of warning letters issued.

Image Source: Google

Type II diabetes is the most frequent type of diabetes, affecting millions of people. Type II diabetes is characterized by the human body not producing sufficient insulin or the cells dismissing the insulin. Insulin enables the body to process and use glucose for energy. Insulin transports sugar in the bloodstream and supplies it as fuel for the cells.

Diabetic complications result when sugar stays in the blood. Symptoms include increased thirst and appetite, frequent urination, dry skin, unexplained weight loss, tingling, blurred vision, headaches, and tiredness.

Like all prescribed drugs, never stop use without first consulting with your doctor. The manufacturers of statins and the physicians who prescribe them have a legal responsibility to notify patients, particularly women, of the danger involved in taking these medications and to execute regular follow-up examinations.